Prescient Therapeutics Limited Stock
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
08:57:39 24/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0720 AUD | -5.26% |
|
-15.29% | -14.29% |
| 08-21 | Prescient Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-03 | Prescient Therapeutics Limited - Special Call |
| Market Cap | 79.92M 57.28M 49.07M 45.91M 42.03M 78.87M 5.48B 542M 212M 2.75B 215M 210M 9.11B | P/E 2025 |
-4.84x | P/E 2026 | -8.97x |
|---|---|---|---|---|---|
| Enterprise Value | 71.09M 50.96M 43.65M 40.84M 37.39M 70.16M 4.88B 483M 188M 2.45B 191M 187M 8.1B | EV / Sales 2025 |
6.54x | EV / Sales 2026 | 15.4x |
| Free-Float |
89.43% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: Prescient Therapeutics Limited
| 1 day | -5.26% | ||
| 1 week | -15.29% | ||
| Current month | -15.29% | ||
| 1 month | -21.74% | ||
| 3 months | -4.00% | ||
| 6 months | +14.29% | ||
| Current year | -14.29% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.07 | | 0.09 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 20/01/2025 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 30/03/2025 |
Allen Ebens
BRD | Director/Board Member | - | 01/06/2020 |
Ellen Feigal
BRD | Director/Board Member | 71 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/2/23 A | Fiscal year | Chief Executive Officer | 1,148,936 | 0.1430% | ||
| 5/2/23 A | Expiration | Chief Executive Officer | 2,351,064 | 0.2926% | ||
| 4/4/23 A | Fiscal year | Chief Executive Officer | 97,692 | 0.0135% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.26% | -15.29% | +67.44% | 0.00% | 57.28M | |
| -0.68% | +3.60% | +2.44% | +22.89% | 51.61B | |
| -1.07% | +2.82% | +465.96% | +570.70% | 44.89B | |
| +1.47% | +9.79% | +35.92% | +20.21% | 42.77B | |
| +1.44% | +7.77% | +19.38% | +84.65% | 42.58B | |
| -0.93% | -4.33% | +16.18% | +55.82% | 31.82B | |
| +1.32% | +7.30% | +33.89% | +148.53% | 17.33B | |
| -0.60% | +1.93% | - | - | 16.63B | |
| +0.36% | +4.40% | +9.50% | +30.55% | 14.76B | |
| +1.28% | +5.41% | +82.40% | +46.13% | 14.09B | |
| Average | -0.27% | +2.83% | +81.46% | +108.83% | 27.65B | |
| Weighted average by Cap. | +0.18% | +4.71% | +99.32% | +141.29% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.36M 3.12M 2.67M 2.5M 2.29M 4.3M 299M 29.57M 11.53M 150M 11.73M 11.47M 496M | 3.59M 2.57M 2.2M 2.06M 1.89M 3.54M 246M 24.36M 9.5M 124M 9.66M 9.45M 409M |
| Net income | -7.32M -5.25M -4.5M -4.21M -3.85M -7.23M -502M -49.7M -19.38M -252M -19.71M -19.28M -834M | -7M -5.02M -4.3M -4.02M -3.68M -6.91M -480M -47.53M -18.54M -241M -18.85M -18.44M -798M |
| Net Debt | -6.93M -4.97M -4.25M -3.98M -3.64M -6.84M -475M -47.02M -18.34M -239M -18.64M -18.24M -789M | -8.83M -6.33M -5.42M -5.07M -4.64M -8.71M -605M -59.9M -23.36M -304M -23.75M -23.24M -1.01B |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/08/26 | A$0.0720 | -5.26% | 894,856 |
| 21/08/26 | A$0.0760 | -1.30% | 599,958 |
| 20/08/26 | A$0.0770 | -2.53% | 2,246,217 |
| 19/08/26 | A$0.0790 | -1.25% | 165,661 |
| 18/08/26 | A$0.0800 | -5.88% | 1,382,412 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
